-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
April 01, 2022 - outcomes of opioid-induced constipation in
patients with chronic non-cancer pain in the
compose phase … Effects
of naltrexone exposure observed in two
phase three studies with ALO-02, an
extended-release … Measuring withdrawal in a phase 3 study of
a new analgesic, nktr-181, in subjects with
moderate to … Measuring Opioid Withdrawal in a Phase 3
Study of a New Analgesic, NKTR-181
(Oxycodegol), in Patients … A
Phase I Placebo-Controlled Trial Comparing
the Effects of Buprenorphine Buccal Film
and Oral Oxycodone
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
October 23, 2014 - For example, liver lesions of less
than 1 cm should be evaluated by 3-phase contrast-enhanced CT, MR … , or
ultrasound, but liver lesions that are greater than 1 cm in size should be
evaluated with 3-phase
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
January 01, 2020 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists three topics for which preliminary phase III or U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/introduction.ppt
January 01, 2010 - important step that is not covered in these training modules occurs during the data extraction and analysis phase … AHRQ Effective Health Care Program
Points of Stakeholder Engagement for Systematic Reviews
Program
Phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
September 13, 2011 - our understanding of the literature and discussions with Key Informants during the topic
refinement phase … Project staff will meet regularly to discuss the results at each phase, to
review studies that are difficult
-
effectivehealthcare.ahrq.gov/sites/default/files/introduction.ppt
January 01, 2010 - important step that is not covered in these training modules occurs during the data extraction and analysis phase … AHRQ Effective Health Care Program
Points of Stakeholder Engagement for Systematic Reviews
Program
Phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
December 06, 2010 - we will retrieve and review the full text of all titles included
during the title/abstract review phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_research-protocol.pdf
December 06, 2010 - we will retrieve and review the full text of all titles included
during the title/abstract review phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - preliminary literature reviews in developing the draft protocol during the Comparative
Effectiveness Review phase … (118498)
21 Single Blind Method/ (17086)
22 clinical trial/ (476450)
23 clinical trial, phase … i.pt. (12809)
24 clinical trial, phase ii.pt. (20505)
25 clinical trial, phase iii.pt. (7571 … )
26 clinical trial, phase iv.pt. (759)
27 controlled clinical trial.pt. (85694)
28 randomized
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
November 28, 2012 - Prospective, randomized, double-blind,
multi-center, Phase III clinical study on transarterial chemoembolization … chemotherapy alone
versus transarterial chemoembolization for hepatocellular carcinoma: A randomized
phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - Tetrahydrocannabinol Does Not
Reduce Pain in Patients With Chronic
Abdominal Pain in a Phase 2 Placebo … Tetrahydrocannabinol Does Not
Reduce Pain in Patients With Chronic
Abdominal Pain in a Phase 2 Placebo … Tetrahydrocannabinol Does Not
Reduce Pain in Patients With Chronic
Abdominal Pain in a Phase 2 Placebo … A Phase
2 Randomised Clinical Trial Assessing the
Tolerability of Two Different Ratios of
Medicinal … Olorinab, a Peripherally Acting, Highly
Selective, Full Agonist of the Cannabinoid
Receptor 2, in a Phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - Tetrahydrocannabinol Does Not
Reduce Pain in Patients With Chronic
Abdominal Pain in a Phase 2 Placebo … Tetrahydrocannabinol Does Not
Reduce Pain in Patients With Chronic
Abdominal Pain in a Phase 2 Placebo … Tetrahydrocannabinol Does Not
Reduce Pain in Patients With Chronic
Abdominal Pain in a Phase 2 Placebo … A Phase
2 Randomised Clinical Trial Assessing the
Tolerability of Two Different Ratios of
Medicinal … Olorinab, a Peripherally Acting, Highly
Selective, Full Agonist of the Cannabinoid
Receptor 2, in a Phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
November 02, 2018 - limit 7 to (adaptive clinical trial or clinical study or clinical trial, all or clinical trial, phase … i
or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or clinical
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - 43, figure 5, should make some comment regarding the
results for serious adverse events for acute phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-evidence-communication_executive.pdf
November 01, 2013 - Communication and Dissemination Strategies To Facilitate the Use of Health-Related Evidence
Evidence Report/Technology Assessment
Number 213
Communication and Dissemination Strategies To
Facilitate the Use of Health-Related Evi…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - responsiveness of three quality of life measures in the assessment
of psoriasis patients: results of a phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
January 01, 2013 - In a topic refinement phase, the
scope of the project was refined with input from a panel
of Key Informants
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
June 04, 2010 - Source: www.effectivehealthcare.ahrq.gov
Published Online: June 04, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of First and Second Generation Antipsychotics in the
Pediatric and Young Adult Populations
I. Background and Objectives for th…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-disposition-comments.pdf
June 16, 2022 - Knowledge and
education were excluded as
outcomes a priori during the
scoping phase of the project … However, search criteria was
reviewed with the TEP and with
AHRQ during the scoping phase
of the project
-
effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
May 05, 2017 - One Phase 1b and two
Phase 3 studies1,2,3 are
relevant to KQ3 as they
contained a TT treatment
arm … Additionally, an ongoing
Phase 3b single-arm study
(NCT02600559)4 that has
N>50 subjects, with TT